Ignite Creation Date:
2024-05-05 @ 9:42 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004039
Status:
WITHDRAWN
Last Update Posted:
2015-08-19
First Post:
1999-12-10
Brief Title:
Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
Sponsor:
Hoag Memorial Hospital Presbyterian
Organization:
Hoag Memorial Hospital Presbyterian
Organization Data
Organization:
Hoag Memorial Hospital Presbyterian
Class:
OTHER
Study ID:
CDR0000066762
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hoag Memorial Hospital Presbyterian
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Robert O Dillman MD
Old Organization:
Hoag Memorial Hospital Presbyterian
Collaborators
| Name | Class |
|---|---|
| Cancer Biotherapy Research Group | OTHER |